NCI Awards Cyntellect $1.3M for Cell Cloning Technology Development | GenomeWeb
NEW YORK (GenomeWeb News) - Cyntellect said today it has received a Phase II Small Business Innovative Research grant from the National Cancer Institute worth $1.3 million to develop applications for its LEAP cell-imaging system.
 
LEAP (Laser-Enabled Analysis and Processing) is designed for high-throughput cell imaging and laser-based cell manipulation, the company said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.